These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 28748389

  • 21. Trabecular Bone Score and Hip Structural Analysis in Patients With Atypical Femur Fractures.
    Buitendijk SKC, van de Laarschot DM, Smits AAA, Koromani F, Rivadeneira F, Beck TJ, Zillikens MC.
    J Clin Densitom; 2019; 22(2):257-265. PubMed ID: 29661684
    [Abstract] [Full Text] [Related]

  • 22. Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy.
    Franceschetti P, Bondanelli M, Caruso G, Ambrosio MR, Lorusso V, Zatelli MC, Massari L, Degli Uberti EC.
    Bone; 2013 Oct; 56(2):426-31. PubMed ID: 23871850
    [Abstract] [Full Text] [Related]

  • 23. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
    Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, Dell RM, Adams AL.
    N Engl J Med; 2020 Aug 20; 383(8):743-753. PubMed ID: 32813950
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
    Weil YA, Rivkin G, Safran O, Liebergall M, Foldes AJ.
    J Trauma; 2011 Jul 20; 71(1):186-90. PubMed ID: 21610533
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
    Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, Tsuchie H, Sasaki H, Kasukawa Y, Shimada Y.
    J Bone Miner Metab; 2015 Sep 20; 33(5):553-9. PubMed ID: 25227287
    [Abstract] [Full Text] [Related]

  • 33. Atypical diaphyseal femoral fractures: Considerations on surgical technique.
    Spinelli MS, Marini E, Daolio PA, Piccioli A.
    Injury; 2019 Jul 20; 50 Suppl 2():S65-S69. PubMed ID: 30782394
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Location of fractures and the characteristics of patients with atypical femoral fractures: analyses of 38 Japanese cases.
    Hyodo K, Nishino T, Kamada H, Nozawa D, Mishima H, Yamazaki M.
    J Bone Miner Metab; 2017 Mar 20; 35(2):209-214. PubMed ID: 27026435
    [Abstract] [Full Text] [Related]

  • 36. Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.
    Qiu S, Dhaliwal R, Divine G, Warner E, Rao SD.
    J Bone Miner Res; 2024 May 02; 39(4):417-424. PubMed ID: 38477744
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
    Phillips HK, Harrison SJ, Akrawi H, Sidhom SA.
    Injury; 2017 Jun 02; 48(6):1159-1164. PubMed ID: 28410753
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.